Keyphrases
Lipoproteins
100%
Coagulation Inhibitors
100%
HepG2
100%
Hepatoma Cells
100%
Hepatoblastoma
100%
Immunoaffinity Purification
100%
Chang Liver
100%
Tissue Factor
23%
Culture Media
19%
Coagulation
19%
Chromatography
14%
Inhibitory Activity
9%
Specific Activity
9%
Human Plasma
9%
Anti-Xa
9%
Amidolysis
9%
Liver
4%
Amino Acids
4%
Post-translational Modification
4%
Terminal Sequence
4%
Reconstitution
4%
Amino
4%
Factor Xa
4%
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE)
4%
Clot
4%
Synthetic Peptides
4%
Polyclonal Antibody
4%
Proteolysis
4%
Unit-based
4%
Plasma Lipoproteins
4%
Carboxyl-terminal Region
4%
Sepharose 4B
4%
Immunoaffinity
4%
Clotting Time
4%
Inhibitor Concentration
4%
Immunoaffinity Chromatography
4%
Clotting Assay
4%
Immunology and Microbiology
Hepatoma Cell
100%
Antibody Affinity
100%
Lipoprotein
100%
Thromboplastin
25%
Blood Plasma
15%
Chromatography
15%
Cell Line
5%
Carboxy Terminal Sequence
5%
Amino Terminal Sequence
5%
Molecular Weight
5%
Leporidae
5%
Absorption
5%
Polyclonal Antibody
5%
Protein Degradation
5%
Clotting Time
5%
Lipoprotein Blood Level
5%
Immunoaffinity Chromatography
5%
Peptides
5%
Post-Translational Modification
5%
Amino Acid
5%
Biochemistry, Genetics and Molecular Biology
Copurification
100%
Tissue Factor Pathway Inhibitor
100%
Antibody Affinity
100%
Thromboplastin
21%
Blood Plasma
13%
C-Terminus
4%
Amino Acids
4%
Posttranslational Modification
4%
N-Terminus
4%
Polyacrylamide Gel Electrophoresis
4%
Leporidae
4%
Molecular Weight
4%
Absorption
4%
Lipoprotein Blood Level
4%
Prothrombinase
4%
Polyclonal Antibody
4%
Proteolysis
4%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Tissue Factor Pathway Inhibitor
100%
Thromboplastin
21%
Sepharose
4%
Leporidae
4%
Polyacrylamide Gel Electrophoresis
4%
Amino Acid
4%
Polyclonal Antibody
4%
Clotting Time
4%
Blood Clotting Factor 10a
4%
Synthetic Peptide
4%
Pooled Plasma (Human)
4%